Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The model and estimator can predict drug exposure in kidney transplant patients well.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.